“…There are a multitude of applications of CNL and PI monitoring in the fields of toxicology, pharmacology, and drug discovery. Xenobiotics, endogenous chemicals, and drug intermediaries are reported to react with DNA, proteins, and host metabolic processes in living organisms. − The reactive tendency of these toxins impedes the ability to monitor their concentration in biological systems directly, but the analysis of the adducted and trapped byproducts is commonly employed to monitor for exposures. , Analysis of GSH-trapped reactive metabolites via CNL monitoring of the pyroglutamic acid moiety (129 Da) , and PI monitoring of the γ-glutamyl-dehydroalanyl-glycine fragment in negative ion mode (272 m / z ) , have been employed to measure reactive metabolites in urine derived from xenobiotics, cigarette smoke, , and drug-induced toxicity. ,,− , Further transformation of GSH via transpeptidase cleavage and subsequent acetylation produces mercapturic acids-conjugates that are commonly assessed via CNL monitoring to evaluate reactive metabolite exposure. ,,, Biomonitoring of phase II metabolites produced through glucuronidation ,,, and sulfation , processes are routinely monitored through CNL and PI approaches. Chemical detoxification is finite with nontrivial levels of various reactive metabolites interacting with host systems by means of covalent modification.…”